Viewing Study NCT06383559


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-01-02 @ 1:39 AM
Study NCT ID: NCT06383559
Status: RECRUITING
Last Update Posted: 2024-04-25
First Post: 2024-04-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module